Article
The frequency and clinicopathological significance of NRAS mutations in primary cutaneous nodular melanoma in Indonesia.
Cancer reports (Hoboken, N.J.) - 1 Jan 2022
Rinonce Hanggoro Tri, Sastri Deflen Jumatul, Trisnawati Fita, Kameswari Bidari, Ferronika Paranita, Irianiwati
Abstract excerpt
BACKGROUND: Melanoma is a lethal skin malignancy with a high risk of metastasis, which prompts a need for research on treatment targets and prognostic factors. Recent studies show that the presence of neuroblastoma RAS viral oncogene homolog (NRAS) mutation can influence cell growth in melanomas. The NRAS mutation, which stimulates the mitogen-activated protein kinase (MAPK) signaling pathway, is associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
